Bradman Lake sheds packaging brands in restructuring
Packaging technology firm Bradman Lake is selling off recently acquired brands Albro, Dico and Gravfil only months after investing in a new multi-million pound manufacturing facility.
Packaging technology firm Bradman Lake is selling off recently acquired brands Albro, Dico and Gravfil only months after investing in a new multi-million pound manufacturing facility.
The mayor of a US city where Covance is planning to build a controversial new preclinical testing facility met last week with the Food and Drug Administration (FDA) and government officials to discuss the animal testing issues surrounding the plans.
Patients suffering from a rare and life threatening blood disorder received a boost when the first ever drug to treat the disease was approved.
Scientists hope to harness the power of Sony's new PlayStation 3 games console to conduct research on protein folding and associated diseases such as Alzheimer's and cancer.
Albany Molecular Research, Ranbaxy Laboratories, IBS Pharma, PhRMA and Globalpharma have all had people on the move in the world of pharmaceutical manufacturing.
A novel drug designed to prevent coronary heart disease has failed a pivotal clinical trial although the developers are hopeful the drug might still win approval.
US contract manufacturer Cook Pharmica has won an industry award for its biopharmaceutical facility.
Baxter has pledged to invest a greater proportion of its profit in R&D, to bring the company in line with other pharma firms.